Related Experiment Video
Updated: Jun 6, 2026
09:18
Laser-heating and Radiance Spectrometry for the Study of Nuclear Materials in Conditions Simulating a Nuclear Power Plant Accident
Published on: December 14, 2017
The UK National Cyclodiode Laser Survey
1Birmingham and Midland Eye Centre, West Birmingham and Sandwell NHS Trust, Birmingham, UK.
Eye (London, England)
|December 4, 2010
Summary
Transscleral diode laser cyclophotocoagulation (cyclodiode) use varies widely among UK ophthalmologists. Current practices may not be optimal, suggesting a need for individualized treatment parameters to improve outcomes in glaucoma management.
Area of Science:
- Ophthalmology
- Glaucoma Management
- Laser Therapy
Background:
- Transscleral diode laser cyclophotocoagulation (cyclodiode) is a treatment for glaucoma.
- Understanding current practices is crucial for optimizing patient care.
Purpose of the Study:
- To evaluate the current practice patterns of transscleral diode laser cyclophotocoagulation among consultant ophthalmologists in the United Kingdom.
Main Methods:
- A 31-question survey was distributed to UK consultant ophthalmologists via email and postal mail.
- The survey collected data on demographic information, laser settings, influencing factors, post-operative care, and repeat treatments.
Main Results:
- 35.3% of respondents perform cyclodiode treatment, with 46.7% being glaucoma subspecialists (GSS).
- Significant variations exist in power settings, number of applications, and use of transillumination between GSS and non-GSS.
- Treatment parameters differ based on eye condition (uveitic glaucoma, blind eyes) and whether combined with cataract surgery.
Conclusions:
- There is considerable variation in cyclodiode laser treatment practices among UK ophthalmologists.
- Current common practices may not represent optimal treatment strategies.
- Individualized treatment parameters tailored to specific eye conditions are recommended for improved outcomes.
